Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FAJRJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,391
Award facts
- Contract value 100% obligated
- $7,390.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $7,390.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pen injections on November 3, 2025, with completion targeted for November 4, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.999 billion prime vendor agreement (SPE2DX) running through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience supplying diverse pharmaceutical commodities including brand-name and generic medications, vaccines, and specialty medical supplies across multiple therapeutic domains. This Zepbound delivery order aligns with AmerisourceBergen's established role in the Defense Health Agency's pharmaceutical supply chain and reflects the company's capability to fulfill specific medication requirements for military personnel through the DLA's centralized procurement processes.
Quick answers
Who was awarded contract SPE2DR26FAJRJ?
SPE2DR26FAJRJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FAJRJ worth?
The government has obligated $7,391 on SPE2DR26FAJRJ.
Is contract SPE2DR26FAJRJ an order under another contract?
Yes. SPE2DR26FAJRJ is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAJRJ competed?
The extent of competition for SPE2DR26FAJRJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award